FORT WASHINGTON, PA (February 13, 2020) — M3 Global Research, the leading healthcare market research company, announces the launch of its new M3 Agile product, designed to deliver quick turnaround research from physicians, and in an industry first, patients, through both quantitative and qualitative methodologies.
Bringing fast insights to qualitative methodologies for the first time, M3 Agile has been developed with industry-leading compliance and adherence to ISO standards aligned with EphMRA, BHBIA, Intellus, and Insights Association.
Created in response to industry trends, the offer is a high value, cost-effective approach, delivering robust insights from both patient and physician respondents via online questionnaires, tele-depth interviews, or a combination of the two methodologies.
M3 Agile combines self-serve technology and an innovative platform with traditional account management support, offering fully compliant fieldwork, with all the benefits of randomly sampling the M3 Global Research proprietary panel, which boasts four million respondents in 248 markets across 70 countries worldwide.
There are three options available, with fieldwork closing as soon as 48 hours post launch:
- Qualitative: Physicians – 20-minute tele-depth interviews (TDIs), available in English, in the US and EU5. Moderated interviews generally begin 48 hours after launch, on an M3 or client-hosted platform, with recording as an option.
- Quantitative: Patients – Access M3 Global Research’s US patient panel, covering over 60 different conditions, with up to 10 questions. Live tracking offers immediate access to responses.
- Quantitative: Physicians – With raw data and data tables typically available 48 hours from launch, clients can ask up to 10 questions to physicians from 16 countries (US, EU5, Nordics, Central Europe, Japan).
“M3 Global Research continues to expand and evolve its research offerings to best serve our clients,” says M3 Global Research CEO Anton Richter. “As experts in healthcare market research, we understand the need to gather insights quickly. M3 Agile has the potential to be transformational, harnessing the power of insights from healthcare stakeholders to inform proposals, expand on outlier responses, and many more varied applications.”
A key M3 Agile feature is an easy-to-use project feasibility and cost calculator that allows clients to select the number of responses needed within a country by medical specialty and patient condition areas. M3 Agile data visuals go beyond basic tabulation to allow for detailed analysis.
“We’ve taken into consideration all the things our clients want in an agile product, combining custom programming with ‘the human touch’ across multiple methodologies,” adds Tom Pugh, M3 Global Research EVP. “In this era of patient centricity and the importance of the patient voice, offering immediate access to both patients and physicians is incredibly exciting.”
To learn more about M3 Agile, visit: https://www.m3globalresearch.com/m3-custom-products.cfm
About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 5.8 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, doctors.net.uk, medigate.net, medlive.cn, and m3india.in. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, France, Japan, China, and India. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Spain, USA, Sweden, China, South Korea, and India.